PMC:7755033 / 49589-49875 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"833","span":{"begin":134,"end":139},"obj":"Gene"},{"id":"834","span":{"begin":123,"end":133},"obj":"Species"},{"id":"835","span":{"begin":97,"end":99},"obj":"Species"},{"id":"836","span":{"begin":223,"end":230},"obj":"Chemical"},{"id":"837","span":{"begin":235,"end":253},"obj":"Chemical"}],"attributes":[{"id":"A833","pred":"tao:has_database_id","subj":"833","obj":"Gene:43740568"},{"id":"A834","pred":"tao:has_database_id","subj":"834","obj":"Tax:2697049"},{"id":"A835","pred":"tao:has_database_id","subj":"835","obj":"Tax:126910"},{"id":"A836","pred":"tao:has_database_id","subj":"836","obj":"MESH:C086979"},{"id":"A837","pred":"tao:has_database_id","subj":"837","obj":"MESH:D006886"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":" 0 Lys1027, Gly1026, Val1022, Ser1012, Val1015, Gln766, Lys768  \nTable 7. Binding energies of WS phytoconstituents with SARS-CoV-2 spike glycoprotein (PDB ID:6VXX) in comparison to FDA approved standard reference drugs (Arbidol and Hydroxychloroquine).\n    AutoDock v4.2.6 AutoDoc"}

{"project":"LitCovid-sentences","denotations":[{"id":"T473","span":{"begin":67,"end":75},"obj":"Sentence"},{"id":"T474","span":{"begin":77,"end":255},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":" 0 Lys1027, Gly1026, Val1022, Ser1012, Val1015, Gln766, Lys768  \nTable 7. Binding energies of WS phytoconstituents with SARS-CoV-2 spike glycoprotein (PDB ID:6VXX) in comparison to FDA approved standard reference drugs (Arbidol and Hydroxychloroquine).\n    AutoDock v4.2.6 AutoDoc"}